Viewing StudyNCT00397046



Ignite Creation Date: 2024-05-05 @ 5:08 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00397046
Status: COMPLETED
Last Update Posted: 2018-09-14
First Post: 2006-11-07

Brief Title: A Study Of The Safety And Tolerability Of HKI-272 Administered Orally To Japanese Subjects With Advanced Solid Tumors
Sponsor: Puma Biotechnology Inc
Organization: Puma Biotechnology Inc

Conditions & Keywords Data

Conditions:
Name
Tumors
Keywords:
Name View
Nerlynx View
Advanced Malignant Solid Tumors View
HKI-272 View
Neratinib View